Form 8-K - Current report:
SEC Accession No. 0000886163-18-000022
Filing Date
2018-02-21
Accepted
2018-02-21 16:06:29
Documents
3
Period of Report
2018-02-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8kearningrelease123117.htm 8-K 20455
2 EXHIBIT 99.1 q42017earningsrelease10k.htm EX-99.1 295345
3 ligandlogoa09.jpg GRAPHIC 36525
  Complete submission text file 0000886163-18-000022.txt   367330
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 18628422
SIC: 2834 Pharmaceutical Preparations